Medication-Assisted Treatment for Opioid Use Disorder: Proceedings of a Workshop—in Brief
||November 30, 2018
Note: Proceedings contain the opinion of the presenters, but do NOT reflect the conclusions of the Health and Medicine Division or the National Academies. Learn more about the differences between Reports and Proceedings.
On October 30 and 31, 2018, the Committee on Medication-Assisted Treatment (MAT) for Opioid Use Disorder (OUD) held a 1.5-day workshop in Washington, DC. To support the dissemination of accurate patient-focused information about treatments for opioid use disorder, and to help provide scientific solutions to the current opioid crisis, an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine was created to conduct a study of the evidence base on Medication-Assisted Treatment (MAT) for Opioid Use Disorder (OUD).
The committee was asked to review the current knowledge and gaps in understanding regarding the effectiveness of MAT for treating OUD, examine the available evidence on the range of parameters and circumstances in which MAT can be effectively delivered, and identify challenges in implementation. The public workshop was designed to bring the committee together with a wide range of clinicians, academic experts, policy makers, and representatives of affected individuals and family members for a full discussion of the current initiatives related to MAT, existing evidence and research gaps, and barriers that discourage access to and use of MAT. This Proceedings of a Workshop—in Brief highlights the presentations and discussions that occurred at the workshop; it should not be seen as reflecting findings, conclusions, or recommendations of the workshop participants or of the committee. The committee’s consensus report will be available in spring 2019.